These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24983266)

  • 1. Prognostic stratification of patients with chronic systolic heart failure using biomarkers and Doppler echocardiography.
    Ghio S; Alessandrino G; Albertini R; Klersy C; Girardi B; Maggi G; Pazzano AS; Raineri C; Scelsi L; Visconti LO
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):470-5. PubMed ID: 24983266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent and incremental prognostic value of Doppler-derived left ventricular total isovolumic time in patients with systolic heart failure.
    Bajraktari G; Dini FL; Fontanive P; Elezi S; Berisha V; Napoli AM; Ciuti M; Henein M
    Int J Cardiol; 2011 May; 148(3):271-5. PubMed ID: 19948365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transthoracic bioimpedance and brain natriuretic peptide assessment for prognostic stratification of outpatients with chronic systolic heart failure.
    Malfatto G; Corticelli A; Villani A; Giglio A; Della Rosa F; Branzi G; Facchini M; Parati G
    Clin Cardiol; 2013 Feb; 36(2):103-9. PubMed ID: 23377871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Bistola V; Parissis JT; Paraskevaidis I; Panou F; Nikolaou M; Ikonomidis I; Flessas N; Filippatos G; Iliodromitis E; Kremastinos DT
    Am J Cardiol; 2010 Jan; 105(2):249-54. PubMed ID: 20102927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis in patients with heart failure and preserved left ventricular systolic function.
    Dias P; Rodrigues RA; Queirós MC; Monteiro E; Pimenta J; Friões F; Ferreira A; Bettencourt P
    Rev Port Cardiol; 2001 Dec; 20(12):1223-32. PubMed ID: 11865682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between B-type natriuretic peptide levels and echocardiographic parameters in patients with heart failure admitted to the emergency department.
    Karakiliç E; Kepez A; Abali G; Coşkun F; Kunt M; Tokgözoğlu L
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):143-9. PubMed ID: 20382614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma metalloproteinase-9 and restrictive filling pattern as major predictors of outcome in patients with ischemic cardiomyopathy.
    Bajraktari G; Miccoli M; Buralli S; Fontanive P; Elezi S; Metelli MR; Baggiani A; Dini FL
    Eur J Intern Med; 2012 Oct; 23(7):616-20. PubMed ID: 22939806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I-II systolic heart failure.
    Dini FL; Fontanive P; Buralli S; Panicucci E; Andreini D; Conti U; De Tommasi SM
    Int J Cardiol; 2009 Aug; 136(2):144-50. PubMed ID: 18649955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease.
    Dini FL; Buralli S; Bajraktari G; Elezi S; Duranti E; Metelli MR; Carpi A; Taddei S
    Biomed Pharmacother; 2010 May; 64(5):339-42. PubMed ID: 19944559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [BNP and echocardiography can predict the occurrence of acute cardiac decompensation during titration of bisoprolol in chronic systolic heart failure].
    Ben Driss A; Tabet JY; Meurin P; Weber H; Renaud N; Grosdemouge A; Bourmayan C
    Arch Mal Coeur Vaiss; 2007 Nov; 100(11):934-40. PubMed ID: 18209694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of tissue Doppler imaging for risk stratification of patients with chronic systolic heart failure with or without restrictive mitral flow.
    Dini FL; Lattanzi F; Fontanive P; Rosa GM; De Tommasi SM
    Eur J Echocardiogr; 2009 Jun; 10(4):562-6. PubMed ID: 19252188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure.
    Nakao S; Goda A; Yuba M; Otsuka M; Matsumoto M; Yoshida C; Ohyanagi M; Naito Y; Lee M; Tsujino T; Masuyama T
    Circ J; 2007 Sep; 71(9):1412-7. PubMed ID: 17721020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of B-type natriuretic peptide for assessment of left ventricular function in patients with chronic kidney disease.
    Soleimani A; Nasiri O; Nikoueinejad H; Mianehsaz E; Yousefzade M; Foroozanfard F; Tabatabaizadeh M; Moraveji SA; Rajali M
    Iran J Kidney Dis; 2011 Jul; 5(4):242-7. PubMed ID: 21725181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.
    Kruszewski K; Scott AE; Barclay JL; Small GR; Croal BL; Møller JE; Oh JK; Hillis GS
    Am Heart J; 2010 Jan; 159(1):47-54. PubMed ID: 20102866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined approach with Doppler echocardiography and B-type natriuretic peptide to stratify prognosis of patients with decompensated systolic heart failure.
    Seo Y; Ishizu T; Kawano S; Watanabe S; Ishimitsu T; Aonuma K
    J Cardiol; 2008 Dec; 52(3):224-31. PubMed ID: 19027600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes.
    Karavidas A; Lazaros G; Matsakas E; Farmakis D; Parissis J; Paraskevaidis IA; Michailidis C; Avramidis D; Zacharoulis A; Arapi S; Kaoukis A; Zacharoulis A
    Heart Vessels; 2008 May; 23(3):181-6. PubMed ID: 18484161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure.
    Tang WH; Shrestha K; Van Lente F; Troughton RW; Martin MG; Borowski AG; Jasper S; Klein AL
    Am J Cardiol; 2008 Feb; 101(3):370-3. PubMed ID: 18237602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.
    Troughton RW; Prior DL; Pereira JJ; Martin M; Fogarty A; Morehead A; Yandle TG; Richards AM; Starling RC; Young JB; Thomas JD; Klein AL
    J Am Coll Cardiol; 2004 Feb; 43(3):416-22. PubMed ID: 15013124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.